CHICAGO EQUITY PARTNERS LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$508,000
+6.3%
15,060
-14.7%
0.02%
+6.7%
Q1 2018$478,000
+61.5%
17,660
-0.6%
0.02%
+66.7%
Q4 2017$296,000
-16.9%
17,7700.0%0.01%
-18.2%
Q3 2017$356,000
-68.8%
17,770
-71.5%
0.01%
-64.5%
Q2 2017$1,142,000
+103.6%
62,290
+9.2%
0.03%
+93.8%
Q1 2017$561,00057,0200.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders